Literature DB >> 11339379

Tetralogy of Fallot associated with chromosome 22q11.2 deletion in adolescents and young adults.

K Momma1, A Takao, R Matsuoka, Y Imai, A Muto, M Osawa, M Takayama.   

Abstract

PURPOSE: To clarify the clinical profiles of adolescents and young adults with tetralogy and 22q11.2 deletion, which has recently been identified as a cause of tetralogy of Fallot in about 15% of patients.
METHODS: Thirty-four patients with 22q11.2 deletion and tetralogy of Fallot, with or without pulmonary atresia, including 15 males and 19 females, with their age ranging from 16 to 35 years (mean = 25) were studied. Main outcome measurements include chromosome deletion identified by fluorescence in situ hybridization (FISH) of peripheral blood lymphocytes, medical states assessed with New York Heart Association classification, social activity assessed with Warnes index, IQ assessed by Wechsler test.
RESULTS: Eighteen of 20 patients with tetralogy and pulmonary stenosis had cardiac repair, and their cardiac conditions were good except one. Of 14 patients with tetralogy with pulmonary atresia, 7 had Rastelli type cardiac repair and were doing well, although 4 of them needed re-operation for conduit stenosis. No cardiac repair was done in the other 7 patients with tetralogy, pulmonary atresia and major collateral arteries because their peripheral pulmonary arteries were too small. In 28 of the 34 patients (82%), overall social activity was limited because of extracardiac diseases, including deafness, club feet, mental retardation, and schizophrenia. The IQ in 17 patients was 59 +/- 13 (mean +/- SD): range 41 to 79. In two patients, repeated IQ study showed a decrease. Four patients developed schizophrenia.
CONCLUSION: Tetralogy with 22q11 deletion can be repaired surgically except in those patients with pulmonary atresia, major collateral arteries, and small peripheral pulmonary arteries. However, most of the adult patients show an inability to function in social life in contrast to most patients with tetralogy but without the deletion, who have a normal social life. Extracardiac diseases, including deafness, club feet, mental retardation, and schizophrenia were major handicaps limiting full social activities in postoperative adolescents and young adults with 22q11.2 deletion and tetralogy.

Entities:  

Mesh:

Year:  2001        PMID: 11339379     DOI: 10.1097/00125817-200101000-00012

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  7 in total

1.  Velocardiofacial syndrome presenting as distal arthrogryposis.

Authors:  Koen Devriendt; Ann Swillen; Marc Gewillig; Jean-Pierre Fryns; Pierre Moens; Luc De Smet
Journal:  Eur J Pediatr       Date:  2004-06       Impact factor: 3.183

2.  Clinical features of 78 adults with 22q11 Deletion Syndrome.

Authors:  Anne S Bassett; Eva W C Chow; Janice Husted; Rosanna Weksberg; Oana Caluseriu; Gary D Webb; Michael A Gatzoulis
Journal:  Am J Med Genet A       Date:  2005-11-01       Impact factor: 2.802

3.  A Rare Triad of Giant Occipital Encephalocele with Lipomyelomeningocele, Tetralogy of Fallot, and Situs Inversus.

Authors:  Arie Franco; Stephanie Y Jo; Amar S Mehta; Dave J Pandya; Carina W Yang
Journal:  J Radiol Case Rep       Date:  2016-03-31

4.  Velo-Cardio-Facial Syndrome.

Authors:  Doron Gothelf; Amos Frisch; Elena Michaelovsky; Abraham Weizman; Robert J Shprintzen
Journal:  J Ment Health Res Intellect Disabil       Date:  2009-04

5.  The fate of children with microdeletion 22q11.2 syndrome and congenital heart defect: clinical course and cardiac outcome.

Authors:  A Kyburz; U Bauersfeld; A Schinzel; M Riegel; M Hug; M Tomaske; E R Valsangiacomo Büchel
Journal:  Pediatr Cardiol       Date:  2007-09-29       Impact factor: 1.655

Review 6.  A cross-comparison of cognitive ability across 8 genomic disorders.

Authors:  Michael Mortillo; Jennifer G Mulle
Journal:  Curr Opin Genet Dev       Date:  2021-05-31       Impact factor: 4.665

Review 7.  Tissue engineering: Relevance to neonatal congenital heart disease.

Authors:  Kevin M Blum; Gabriel J M Mirhaidari; Christopher K Breuer
Journal:  Semin Fetal Neonatal Med       Date:  2021-02-27       Impact factor: 3.726

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.